There is a serious lack of controlled studies on the pharmacological treatment of primary migraine in the developmental age; there is, consequently, an urgent need for new, evidence-based approaches to this long-neglected field of research. Moreover, previous studies have stated that the placebo response is greater in pediatric patients than in adults and that a reduction in the attack frequency in the absence of any pharmacological treatment is observed more frequently in pediatric migraine patients than in adults. Besides these preliminary considerations, the shorter duration of migraine attacks and other characteristic semeiological features of the clinical picture in children are such that the design of randomized controlled trial (RCT) is more problematic in the developmental age than in the adult. Bearing in mind all these weak points, the aim of this review was to summarize and update recent guidelines for the treatment of primary migraine in children and adolescents. The most recent guidelines are those published by the Italian Society for the study of Headache, the French Society for the study of Migraine and Headache, and the American Academy of Neurology. We have incorporated into these guidelines the results from the few, recent RCTs, clinical controlled trials, open-label studies, meta-analyses and reviews that have been published since 2004; owing to the lack of strong evidence in this field of research, we have sometimes even mentioned pilot noncontrolled studies, case series and expert opinions. Lastly, evidence was classified and the recommendations were categorized according to different levels.

Migraine treatment in developmental age: guidelines update / Papetti, Laura; Spalice, Alberto; Nicita, Francesco; Paolino, Maria Chiara; Castaldo, Rosa; Iannetti, Paola; Villa, Maria Pia; Parisi, Pasquale. - In: THE JOURNAL OF HEADACHE AND PAIN. - ISSN 1129-2377. - STAMPA. - 11:3(2010), pp. 267-276. [10.1007/s10194-010-0205-4]

Migraine treatment in developmental age: guidelines update

Papetti, Laura;Spalice, Alberto;Nicita, Francesco;Paolino, Maria Chiara;Castaldo, Rosa;Iannetti, Paola;Villa, Maria Pia;Parisi, Pasquale
2010

Abstract

There is a serious lack of controlled studies on the pharmacological treatment of primary migraine in the developmental age; there is, consequently, an urgent need for new, evidence-based approaches to this long-neglected field of research. Moreover, previous studies have stated that the placebo response is greater in pediatric patients than in adults and that a reduction in the attack frequency in the absence of any pharmacological treatment is observed more frequently in pediatric migraine patients than in adults. Besides these preliminary considerations, the shorter duration of migraine attacks and other characteristic semeiological features of the clinical picture in children are such that the design of randomized controlled trial (RCT) is more problematic in the developmental age than in the adult. Bearing in mind all these weak points, the aim of this review was to summarize and update recent guidelines for the treatment of primary migraine in children and adolescents. The most recent guidelines are those published by the Italian Society for the study of Headache, the French Society for the study of Migraine and Headache, and the American Academy of Neurology. We have incorporated into these guidelines the results from the few, recent RCTs, clinical controlled trials, open-label studies, meta-analyses and reviews that have been published since 2004; owing to the lack of strong evidence in this field of research, we have sometimes even mentioned pilot noncontrolled studies, case series and expert opinions. Lastly, evidence was classified and the recommendations were categorized according to different levels.
2010
adolescent; age factors; central nervous system; child; clinical trials as topic; humans; migraine disorders; neurology; pediatrics; practice guidelines as topic; neurology (clinical); anesthesiology and pain medicine
01 Pubblicazione su rivista::01a Articolo in rivista
Migraine treatment in developmental age: guidelines update / Papetti, Laura; Spalice, Alberto; Nicita, Francesco; Paolino, Maria Chiara; Castaldo, Rosa; Iannetti, Paola; Villa, Maria Pia; Parisi, Pasquale. - In: THE JOURNAL OF HEADACHE AND PAIN. - ISSN 1129-2377. - STAMPA. - 11:3(2010), pp. 267-276. [10.1007/s10194-010-0205-4]
File allegati a questo prodotto
File Dimensione Formato  
Papetti_Migraine-treatment_2010.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 216.71 kB
Formato Adobe PDF
216.71 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1098903
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 35
  • ???jsp.display-item.citation.isi??? 33
social impact